{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:07:58Z","timestamp":1789826878337,"version":"4.0.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Dyslipidemia, in particular elevated triglycerides (TGs) contribute to increased cardiovascular risk in type 2 diabetes mellitus (T2DM). In this pilot study we aimed to assess how increased TGs affect hepatic fat as well as polyunsaturated fatty acid (PUFA) metabolism and oxylipin formation in T2DM patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>40 patients with T2DM were characterized analyzing routine lipid blood parameters, as well as medical history and clinical characteristics. Patients were divided into a hypertriglyceridemia (HTG) group (TG \u2265 1.7mmol\/l) and a normal TG group with TGs within the reference range (TG &amp;lt; 1.7mmol\/l). Profiles of PUFAs and their oxylipins in plasma were measured by gas chromatography and liquid chromatography\/tandem mass spectrometry. Transient elastography (TE) was used to assess hepatic fat content measured as controlled attenuation parameter (CAP) (in dB\/m) and the degree of liver fibrosis measured as stiffness (in kPa).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mean value of hepatic fat content measured as CAP as well as body mass index (BMI) were significantly higher in patients with high TGs as compared to those with normal TGs, and correlation analysis showed higher concentrations of TGs with increasing CAP and BMI scores in patients with T2DM. There were profound differences in plasma oxylipin levels between these two groups. Cytochrome P450 (CYP) and lipoxygenase (LOX) metabolites were generally more abundant in the HTG group, especially those derived from arachidonic acid (AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), \u03b3-linolenic acid (\u03b3-LA), and \u03b1-linolenic acid (\u03b1-LA), and a strong correlation between TG levels and plasma metabolites from different pathways was observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In adult patients with T2DM, elevated TGs were associated with increased liver fat and BMI. Furthermore, these patients also had significantly higher plasma levels of CYP- and LOX- oxylipins, which could be a novel indicator of increased inflammatory pathway activity, as well as a novel target to dampen this activity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1195247","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T09:07:59Z","timestamp":1692349679000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Bioactive oxylipins in type 2 diabetes mellitus patients with and without hypertriglyceridemia"],"prefix":"10.3389","volume":"14","author":[{"given":"Yanan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pietzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Rohwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelheid","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten H.","family":"Weylandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Elbelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.8.863","article-title":"Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications","volume":"44","author":"Unger","year":"1995","journal-title":"Diabetes"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2337\/diabetes.51.1.7","article-title":"Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes","volume":"51","author":"McGarry","year":"2002","journal-title":"Diabetes"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"The Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2022.02.011","article-title":"Dyslipidemia in diabetes: when and how to treat","volume":"51","author":"Goldberg","year":"2022","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-022-01530-8","article-title":"Normal fasting triglyceride levels and incident type 2 diabetes in the general population","volume":"21","author":"Szili-Torok","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/ijms23020766","article-title":"Essential polyunsaturated fatty acids in blood from patients with and without catheter-proven coronary artery disease","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2022.02.001","article-title":"A more atherogenic lipoprotein status is present in adults with type 2 diabetes mellitus than in those without with equivalent degrees of hypertriglyceridemia","volume":"46","author":"Sun","year":"2022","journal-title":"Can J Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pharmthera.2017.10.016","article-title":"Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases","volume":"183","author":"Schunck","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2022.102456","article-title":"The effects of omega-3 fatty acids in type 2 diabetes: a systematic review and meta-analysis","volume":"182","author":"Xiao","year":"2022","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/83.6.1505S","article-title":"N\u2013 3 polyunsaturated fatty acids, inflammation, and inflammatory diseases","volume":"83","author":"Calder","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2008.12.022","article-title":"A systemic review of the roles of n-3 fatty acids in health and disease","volume":"109","author":"Riediger","year":"2009","journal-title":"J Am Dietetic Assoc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27289","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the welcome* study","volume":"60","author":"Scorletti","year":"2014","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"Jama"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin e after myocardial infarction: results of the GISSI-prevenzione trial. gruppo italiano per lo studio della sopravvivenza nell'Infarto miocardico","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M047357","article-title":"Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway","volume":"55","author":"Fischer","year":"2014","journal-title":"J Lipid Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jpen.2448","article-title":"Impact of intravenous fish oil on omega-3 fatty acids and their derived lipid metabolites in patients with parenteral nutrition","volume":"47","author":"Weylandt","year":"2023","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.02.103","article-title":"Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily","volume":"329","author":"Barbosa-Sicard","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(10)70311-X","article-title":"Cytochrome P450\u2013dependent metabolism of \u03c9-6 and \u03c9-3 long-chain polyunsaturated fatty acids","volume":"62","author":"Arnold","year":"2010","journal-title":"Pharmacol Rep"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.838782","article-title":"Formation, signaling and occurrence of specialized pro-resolving lipid mediators\u2014what is the evidence so far","author":"Schebb","year":"2022","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1422590112","article-title":"Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides","volume":"112","author":"L\u00f3pez-Vicario","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13844","article-title":"Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease","volume":"174","author":"Wang","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"8267","DOI":"10.3390\/ijms22158267","article-title":"Differential effects of 17, 18-EEQ and 19, 20-EDP combined with soluble epoxide hydrolase inhibitor t-TUCB on diet-induced obesity in mice","volume":"22","author":"Yang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prostaglandins.2012.01.005","article-title":"Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation","volume":"97","author":"Weylandt","year":"2012","journal-title":"Prostaglandins & other lipid mediators"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2017.01.034","article-title":"Obesity is positively associated with arachidonic acid-derived 5-and 11-hydroxyeicosatetraenoic acid (HETE)","volume":"70","author":"Pickens","year":"2017","journal-title":"Metabolism"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1086\/683695","article-title":"Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension","volume":"5","author":"Ross","year":"2015","journal-title":"Pulmonary Circ"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12941","article-title":"12 (S)-hydroxyeicosatetraenoic acid impairs vascular endothelial permeability by altering adherens junction phosphorylation levels and affecting the binding and dissociation of its components in high glucose-induced vascular injury","volume":"10","author":"Wang","year":"2019","journal-title":"J Diabetes Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"106485","DOI":"10.1016\/j.prostaglandins.2020.106485","article-title":"20-HETE interferes with insulin signaling and contributes to obesity-driven insulin resistance","volume":"152","author":"Gilani","year":"2021","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American heart association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00284-9","article-title":"Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia","volume":"10","author":"Lewis","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2091-6-5","article-title":"A simplified method for analysis of polyunsaturated fatty acids","volume":"6","author":"Kang","year":"2005","journal-title":"BMC Biochem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3892\/br.2014.309","article-title":"Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes","volume":"2","author":"Tomizawa","year":"2014","journal-title":"Biomed Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.018","article-title":"Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations","volume":"60","author":"de L\u00e9dinghen","year":"2014","journal-title":"J Hepatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2006.10.001","article-title":"Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease","volume":"12","author":"Videla","year":"2006","journal-title":"Trends Mol Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-010-0122-6","article-title":"The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes","volume":"10","author":"Cusi","year":"2010","journal-title":"Curr Diabetes Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13219","article-title":"Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease","volume":"31","author":"de L\u00e9dinghen","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29489","article-title":"Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease","volume":"67","author":"Vuppalanchi","year":"2018","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17397","article-title":"Original article: the prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndrome","volume":"57","author":"Fu","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3945\/ajcn.2008.26761","article-title":"Association of serum n-6 and n-3 polyunsaturated fatty acids with lipids in 3 populations of middle-aged men","volume":"90","author":"Motoyama","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"B44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jacl.2013.10.003","article-title":"Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr lowering very high triglyceridEs (EVOLVE) trial","volume":"8","author":"Kastelein","year":"2014","journal-title":"J Clin Lipidol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqac150","article-title":"Associations of serum n\u20133 and n\u20136 polyunsaturated fatty acids with prevalence and incidence of nonalcoholic fatty liver disease","volume":"116","author":"M\u00e4kel\u00e4","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2017.11.009","article-title":"Palmitic and oleic acid: the yin and yang of fatty acids in type 2 diabetes mellitus","volume":"29","author":"Palomer","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.plefa.2013.04.001","article-title":"Comparison of free serum oxylipin concentrations in hyper-vs. normolipidemic men","volume":"89","author":"Schuchardt","year":"2013","journal-title":"Prostaglandins Leukotrienes Essential Fatty Acids"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2007.02.001","article-title":"Correlation of triacylglycerol oligopolymers and oxidised triacylglycerols to quality parameters in extra virgin olive oil during storage","volume":"40","author":"Bilancia","year":"2007","journal-title":"Food Res Int"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50307","article-title":"Central role of PPAR\u03b1-dependent hepatic lipid turnover in dietary steatohepatitis in mice","volume":"38","author":"Ip","year":"2003","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2004.01.011","article-title":"Is autism a disorder of fatty acid metabolism? possible dysfunction of mitochondrial \u03b2-oxidation by long chain acyl-CoA dehydrogenase","volume":"62","author":"Clark-Taylor","year":"2004","journal-title":"Med Hypotheses"},{"key":"B51","doi-asserted-by":"publisher","first-page":"11688","DOI":"10.3390\/ijms231911688","article-title":"The plasma oxylipin signature provides a deep phenotyping of metabolic syndrome complementary to the clinical criteria","volume":"23","author":"Dalle","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.plefa.2015.12.001","article-title":"Influence of weight reduction on blood levels of c-reactive protein, tumor necrosis factor-\u03b1, interleukin-6, and oxylipins in obese subjects","volume":"106","author":"Moeller","year":"2016","journal-title":"Prostaglandins Leukotrienes Essential Fatty Acids"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100073","article-title":"The lipidome in nonalcoholic fatty liver disease: actionable targets","volume":"62","author":"Pirola","year":"2021","journal-title":"J Lipid Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P055640","article-title":"Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis","volume":"56","author":"Loomba","year":"2015","journal-title":"J Lipid Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2020.102229","article-title":"Regulation of the cytochrome P450 epoxyeicosanoid pathway is associated with distinct histologic features in pediatric non-alcoholic fatty liver disease","volume":"164","author":"Kalveram","year":"2021","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2014.10.008","article-title":"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid","volume":"1851","author":"Powell","year":"2015","journal-title":"Biochim Biophys Acta (BBA)-Molecular Cell Biol Lipids"},{"key":"B58","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/FJC.0b013e3181f04b1c","article-title":"20-HETE: a new target for the treatment of hypertension","volume":"56","author":"Williams","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2001.280.6.H2430","article-title":"EET homologs potently dilate coronary microvessels and activate BKCa channels","volume":"280","author":"Zhang","year":"2001","journal-title":"Am J Physiology-Heart Circulatory Physiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-6250fje","article-title":"Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA","volume":"20","author":"Gonz\u00e1lez-P\u00e9riz","year":"2006","journal-title":"FASEB J"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1195247\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T09:08:12Z","timestamp":1692349692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1195247\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":60,"alternative-id":["10.3389\/fendo.2023.1195247"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1195247","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"article-number":"1195247"}}